Related Experiment Video
Updated: Aug 5, 2026

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability
Published on: April 22, 2016
Itaconic acid biomanufacturing: metabolic engineering and green process development
Jiaqi Yu1,2,3, Zhiwen Wang1,2,4, Tao Chen1,2,3
1State Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, P. R. China.
This review explores metabolic engineering and bioprocess innovations to improve itaconic acid (IA) production. It highlights strategies for sustainable, cost-effective IA biosynthesis using renewable resources and AI.
Area of Science:
- Biotechnology
- Metabolic Engineering
- Bioprocess Engineering
Background:
- Itaconic acid (IA) is a versatile unsaturated dicarboxylic acid with broad industrial, medical, food, and energy applications.
- Biotechnological IA production offers sustainability and control but faces cost, efficiency, and separation challenges.
Purpose of the Study:
- To review recent advances and key technologies in itaconic acid biosynthesis.
- To analyze engineering strategies for improved IA production and address industrialization barriers.
Main Methods:
- Analysis of metabolic engineering strategies for *de novo* IA production.
- Discussion of whole-cell catalysis and fermentation process optimization.
- Review of renewable substrates and AI-assisted strain engineering for IA biosynthesis.
Main Results:
- Identified engineering strategies to enhance IA yield and substrate utilization.
- Examined the application of renewable resources and green process technologies.
- Highlighted the potential of AI in optimizing IA production.
Conclusions:
- Metabolic engineering and bioprocess innovations are crucial for cost-effective and sustainable IA production.
- Future directions include AI-assisted engineering and low-carbon processes for industrial IA biosynthesis.
Related Concept Videos
Production of Pharmaceuticals
Upstream Processing
Production of Organic Acids
Amino Acid Biosynthetic Pathways
Bioreactor Design and Operational System
Production of Antibiotics

